$56.25
0.11% yesterday
Nasdaq, Aug 11, 10:00 pm CET
ISIN
US9174881089
Symbol
UTMD

Utah Medical Products, Inc. Stock price

$56.25
-0.18 0.32% 1M
-4.79 7.85% 6M
-5.22 8.49% YTD
-10.25 15.41% 1Y
-37.06 39.72% 3Y
-24.55 30.38% 5Y
+5.19 10.16% 10Y
+33.13 143.30% 20Y
Nasdaq, Closing price Mon, Aug 11 2025
-0.06 0.11%

Key metrics

Basic
Market capitalization
$182.7m
Enterprise Value
$99.4m
Net debt
positive
Cash
$83.3m
Shares outstanding
3.3m
Valuation (TTM | estimate)
P/E
14.4 | -
P/S
4.7 | -
EV/Sales
2.5 | -
EV/FCF
7.3
P/B
1.6
Dividends
DPS
$1.21
Yield 1Y | 5Y
2.1% | 1.3%
Growth 1Y | 5Y
1.7% | 2.1%
Payout 1Y | 3Y
30.4% | 27.2%
Increased
3 Years
Financials (TTM | estimate)
Revenue
$39.3m | -
EBITDA
$15.7m | -
EBIT
$12.9m | -
Net Income
$13.0m | -
Free Cash Flow
$13.6m
Growth (TTM | estimate)
Revenue
-19.9% | -
EBITDA
-26.8% | -
EBIT
-20.7% | -
Net Income
-20.9% | -
Free Cash Flow
-32.0%
Margin (TTM | estimate)
Gross
58.4%
EBITDA
40.0% | -
EBIT
32.8%
Net
33.0% | -
Free Cash Flow
34.7%
Financial Health
Equity Ratio
95.8%
Return on Equity
11.8%
ROCE
10.9%
ROIC
-
Debt/Equity
0.0
More
EPS
$3.9
FCF per Share
$4.2
Short interest
3.6%
Employees
161
Rev per Employee
$250.0k
Show more

Is Utah Medical Products, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,025 stocks worldwide.

Financial data from Utah Medical Products, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
39 39
20% 20%
100%
- Direct Costs 16 16
19% 19%
42%
23 23
21% 21%
58%
- Selling and Administrative Expenses 9.35 9.35
22% 22%
24%
- Research and Development Expense 0.70 0.70
3% 3%
2%
16 16
27% 27%
40%
- Depreciation and Amortization 2.84 2.84
46% 46%
7%
EBIT (Operating Income) EBIT 13 13
21% 21%
33%
Net Profit 13 13
21% 21%
33%

In millions USD.

Don't miss a Thing! We will send you all news about Utah Medical Products, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Utah Medical Products, Inc. Stock News

Neutral
Accesswire
14 days ago
SALT LAKE CITY, UT / ACCESS Newswire / July 29, 2025 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty and one-half cents ($.305) per share of common stock payable on October 2, 2025 to stockholders of record at the close of business on September 17, 2025. This is a 1.7% increase over the dividend declared in the same ...
Negative
The Motley Fool
18 days ago
Utah Medical Products Reports Q2 Decline
Neutral
Accesswire
19 days ago
SALT LAKE CITY, UT / ACCESS Newswire / July 24, 2025 / Utah Medical Products, Inc. [Nasdaq:UTMD] reports second calendar quarter (2Q) and first half (1H) 2025 financial results which are consistent with overall beginning-of-year projections. Currencies in this release are denoted as $ or USD = U.S. Dollars; AUD = Australia Dollars; £ or GBP = UK Pound Sterling; C$ or CAD = Canadian Dollars; and...
More Utah Medical Products, Inc. News

Company Profile

Utah Medical Products, Inc. engages in the manufacturing, developing, and marketing of disposable and reusable medical devices. It focuses on the healthcare of women and babies. Its products are used for blood pressure monitoring and blood collection, electrosurgery, gynecology, neonatal critical care, perinatology, and urology. The company was founded on April 21, 1978 and is headquartered in Midvale, UT.

Head office United States
CEO Kevin Cornwell
Employees 161
Founded 1978
Website www.utahmed.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today